QAC-24540-95671
3 vaccinations
1 coded response
11 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 21-25
- ZIP prefix
- 287 / NC
- Registered
- 2021-10-27
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-14
Dose 1 — Pfizer-BioNTech
-
2021-04-04
Dose 2 — Pfizer-BioNTech
-
2021-10-27
Registered in v-safe
-
2021-10-27
Dose 3 — Pfizer-BioNTechCo-administered: Flu
- 2021-10-29
- 2021-10-31
- 2021-11-01
- 2021-11-03
- 2021-11-11
- 2021-11-17
- 2021-11-24
-
2021-12-01
Survey response — day 35, dose 3MedDRA: Nasopharyngitis, Oropharyngeal pain, Respiratory tract congestion — Feeling: Poor · Be unable to do your normal daily activitiesFree text: I have a cold. Sore throat and congestion.MedDRA releases: 2024-11 · check-in free text available
- 2021-12-11
- 2022-01-26
- 2022-04-27
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-14 | Pfizer-BioNTech | No |
| 2 | 2021-04-04 | Pfizer-BioNTech | No |
| 3 | 2021-10-27 | Pfizer-BioNTech | Flu |
Free text
Release 10 — day 35, dose 3
Symptoms: I have a cold. Sore throat and congestion.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release